NCT05810870
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05810870
Title PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin (SABINA)
Acronym SABINA
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitario Clínico San Cecilio de Granada Granada Andalusia 18016 Spain Details
Hospital Universitario Virgen del Rocio Seville Andalusia 41013 Spain Details
Onkologikoa Donostia / San Sebastian Basque Country 20014 Spain Details
Hospital Universitario Marqués de Valdecilla Santander Cantabria 39008 Spain Details
Centro Oncológico de Galicia A Coruña Galicia 15009 Spain Details
Hospital Universitario de Torrejón Torrejón de Ardoz Madrid 28850 Spain Details
CHUVI - Complejo Hospitalario Universitario de Vigo Vigo Pontevedra 36312 Spain Details
Hospital Clínic i Provincial de Barcelona Barcelona 08036 Spain Details
Institut Català d' Oncologia L'Hospitalet (ICO) Barcelona 08907 Spain Details
Hospital Universitari Vall D'Hebron Barcelona Spain Details
Hospital Clínico San Carlos Madrid 28040 Spain Details
Hospital Beata María Ana Madrid Spain Details
Instituto Valenciano de Oncología (IVO) Valencia 46009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field